))
Microdosing Ozempic? The GLP-1 Comeback You Didn’t See Coming
Manage episode 476650822 series 3361220
Gut Check Project에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Gut Check Project 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
The boys are back—new (temporary) studio, same no-BS approach.
Dr. Ken Brown and Eric Rieger dive deep into the unexpected resurgence of GLP-1 medications like Ozempic and Wegovy—this time, with a controversial twist: microdosing. Is less actually more? Can tiny doses of these peptides do more than just shed pounds? Think anxiety relief, autoimmune improvement, and possibly ditching antidepressants altogether. 🤯
In this episode, you’ll learn:
- Why the original weight-loss hype may have missed the mark
- The shocking mental health benefits patients are reporting
- How the gut-brain axis could be the key to mood, metabolism & more
- The dark side of big doses: muscle loss, acid reflux, thyroid risks, and sky-high costs
- Why doctors are thinking outside the FDA box—and what it could mean for you
Whether you’ve tried these meds, are skeptical, or are just here for the banter, this episode blends science, sarcasm, and some serious truth bombs.
🎧 Tap play. This one’s for anyone who’s tired of one-size-fits-all medicine and wants to explore the future of gut-driven wellness.
158 에피소드
공유
